Tower Research Capital (TRC)’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $165K | Sell |
593
-152
| -20% | -$43.8K | ﹤0.01% | 1763 |
|
|
2025
Q4 | $226K | Sell |
745
-551
| -43% | -$172K | 0.01% | 1355 |
|
|
2025
Q3 | $363K | Buy |
1,296
+430
| +50% | +$117K | 0.01% | 1063 |
|
|
2025
Q2 | $209K | Sell |
866
-847
| -49% | -$200K | 0.01% | 1735 |
|
|
2025
Q1 | $417K | Buy |
1,713
+546
| +47% | +$164K | 0.01% | 936 |
|
|
2024
Q4 | $383K | Sell |
1,167
-1,415
| -55% | -$480K | 0.01% | 1247 |
|
|
2024
Q3 | $864K | Buy |
2,582
+1,810
| +234% | +$575K | 0.02% | 606 |
|
|
2024
Q2 | $211K | Sell |
772
-650
| -46% | -$189K | ﹤0.01% | 2033 |
|
|
2024
Q1 | $492K | Sell |
1,422
-1,992
| -58% | -$655K | 0.01% | 876 |
|
|
2023
Q4 | $1.1M | Buy |
3,414
+2,636
| +339% | +$826K | 0.01% | 790 |
|
|
2023
Q3 | $279K | Buy |
778
+327
| +73% | +$126K | 0.01% | 1226 |
|
|
2023
Q2 | $171K | Sell |
451
-464
| -51% | -$189K | 0.01% | 1666 |
|
|
2023
Q1 | $438K | Buy |
915
+430
| +89% | +$201K | 0.01% | 909 |
|
|
2022
Q4 | $204K | Sell |
485
-8,094
| -94% | -$3.27M | 0.01% | 1295 |
|
|
2022
Q3 | $3.58M | Buy |
8,579
+6,724
| +362% | +$3.35M | 0.06% | 258 |
|
|
2022
Q2 | $919K | Sell |
1,855
-685
| -27% | -$357K | 0.02% | 746 |
|
|
2022
Q1 | $1.43M | Buy |
2,540
+1,310
| +107% | +$790K | 0.01% | 668 |
|
|
2021
Q4 | $930K | Buy |
1,230
+826
| +204% | +$618K | 0.02% | 736 |
|
|
2021
Q3 | $301K | Sell |
404
-217
| -35% | -$163K | 0.01% | 1406 |
|
|
2021
Q2 | $400K | Sell |
621
-1,235
| -67% | -$752K | 0.01% | 1364 |
|
|
2021
Q1 | $1.06M | Buy |
1,856
+1,621
| +690% | +$960K | 0.02% | 754 |
|
|
2020
Q4 | $137K | Sell |
235
-48
| -17% | -$27.3K | ﹤0.01% | 2056 |
|
|
2020
Q3 | $146K | Sell |
283
-1,922
| -87% | -$973K | ﹤0.01% | 2839 |
|
|
2020
Q2 | $996K | Buy |
+2,205
| New | +$973K | 0.04% | 532 |
|
|
2019
Q4 | – | Sell |
-773
| Closed | -$257K | – | 3558 |
|
|
2019
Q3 | $257K | Buy |
773
+466
| +152% | +$152K | 0.02% | 876 |
|
|
2019
Q2 | $96K | Sell |
307
-1,254
| -80% | -$375K | 0.01% | 1196 |
|
|
2019
Q1 | $477K | Buy |
1,561
+1,443
| +1,223% | +$389K | 0.03% | 625 |
|
|
2018
Q4 | $27K | Sell |
118
-2,076
| -95% | -$557K | ﹤0.01% | 1698 |
|
|
2018
Q3 | $686K | Buy |
2,194
+2,037
| +1,297% | +$632K | 0.05% | 342 |
|
|
2018
Q2 | $45K | Sell |
157
-1,649
| -91% | -$455K | ﹤0.01% | 1903 |
|
|
2018
Q1 | $452K | Buy |
1,806
+1,246
| +223% | +$317K | 0.04% | 524 |
|
|
2017
Q4 | $134K | Buy |
560
+419
| +297% | +$102K | 0.02% | 734 |
|
|
2017
Q3 | $31K | Buy |
+141
| New | +$31.7K | ﹤0.01% | 2407 |
|
|
2017
Q2 | – | Sell |
-13
| Closed | -$3K | – | 2725 |
|
|
2017
Q1 | $3K | Sell |
13
-870
| -99% | -$168K | ﹤0.01% | 2442 |
|
|
2016
Q4 | $161K | Buy |
883
+226
| +34% | +$38.5K | 0.02% | 724 |
|
|
2016
Q3 | $108K | Buy |
657
+611
| +1,328% | +$92.7K | 0.01% | 773 |
|
|
2016
Q2 | $7K | Buy |
+46
| New | +$6.56K | ﹤0.01% | 3111 |
|
|
2016
Q1 | – | Sell |
-100
| Closed | -$14K | – | 4125 |
|
|
2015
Q4 | $14K | Sell |
100
-1,026
| -91% | -$142K | ﹤0.01% | 1672 |
|
|
2015
Q3 | $151K | Buy |
+1,126
| New | +$162K | 0.01% | 379 |
|
|
2015
Q2 | – | Sell |
-60
| Closed | -$8K | – | 4390 |
|
|
2015
Q1 | $8K | Sell |
60
-740
| -93% | -$91.7K | ﹤0.01% | 2939 |
|
|
2014
Q4 | $96K | Sell |
800
-722
| -47% | -$83.1K | 0.01% | 692 |
|
|
2014
Q3 | $173K | Buy |
1,522
+1,132
| +290% | +$134K | 0.02% | 587 |
|
|
2014
Q2 | $47K | Buy |
+390
| New | +$47.6K | 0.01% | 1330 |
|
|
2014
Q1 | – | Sell |
-28
| Closed | -$3K | – | 4442 |
|
|
2013
Q4 | $3K | Sell |
28
-672
| -96% | -$81.9K | ﹤0.01% | 3815 |
|
|
2013
Q3 | $82K | Buy |
700
+93
| +15% | +$11K | 0.01% | 1472 |
|
|
2013
Q2 | $68K | Buy |
+607
| New | +$71.2K | 0.01% | 721 |
|
Other funds holding BIO
VCM
VPM
AI
